# Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda

> **NCT00405821** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 440 (actual)

## Conditions studied

- HIV Infections
- Herpes Genitalis

## Interventions

- **DRUG:** Acyclovir
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00405821
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2010-10
- **Final completion:** 2010-11
- **Target enrollment:** 440 (ACTUAL)
- **Last updated:** 2012-09-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00405821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00405821, "Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00405821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*